1. Home
  2. PNTG vs VERV Comparison

PNTG vs VERV Comparison

Compare PNTG & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • VERV
  • Stock Information
  • Founded
  • PNTG 2019
  • VERV 2018
  • Country
  • PNTG United States
  • VERV United States
  • Employees
  • PNTG N/A
  • VERV N/A
  • Industry
  • PNTG Medical/Nursing Services
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • PNTG Health Care
  • VERV Health Care
  • Exchange
  • PNTG Nasdaq
  • VERV Nasdaq
  • Market Cap
  • PNTG 873.8M
  • VERV 1.0B
  • IPO Year
  • PNTG N/A
  • VERV 2021
  • Fundamental
  • Price
  • PNTG $22.57
  • VERV N/A
  • Analyst Decision
  • PNTG Buy
  • VERV Buy
  • Analyst Count
  • PNTG 6
  • VERV 11
  • Target Price
  • PNTG $34.50
  • VERV $14.57
  • AVG Volume (30 Days)
  • PNTG 279.6K
  • VERV 4.1M
  • Earning Date
  • PNTG 08-06-2025
  • VERV 08-07-2025
  • Dividend Yield
  • PNTG N/A
  • VERV N/A
  • EPS Growth
  • PNTG 40.99
  • VERV N/A
  • EPS
  • PNTG 0.76
  • VERV N/A
  • Revenue
  • PNTG $748,167,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • PNTG $25.01
  • VERV $47.32
  • Revenue Next Year
  • PNTG $8.18
  • VERV N/A
  • P/E Ratio
  • PNTG $30.18
  • VERV N/A
  • Revenue Growth
  • PNTG 30.04
  • VERV 271.44
  • 52 Week Low
  • PNTG $21.18
  • VERV $2.87
  • 52 Week High
  • PNTG $37.13
  • VERV $11.41
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 29.69
  • VERV 9.97
  • Support Level
  • PNTG $22.23
  • VERV $10.91
  • Resistance Level
  • PNTG $23.56
  • VERV $11.25
  • Average True Range (ATR)
  • PNTG 0.76
  • VERV 0.08
  • MACD
  • PNTG -0.05
  • VERV -1.49
  • Stochastic Oscillator
  • PNTG 8.63
  • VERV 0.00

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: